Overview

Neoadjuvant Chemotherapy for Patients With Squamous Cell Carcinoma of the Penis

Status:
Completed
Trial end date:
2010-08-01
Target enrollment:
Participant gender:
Summary
Primary Objective: -To evaluate the feasibility and efficacy of multimodality treatment (neoadjuvant chemotherapy prior to extirpative surgery) for clinical stage TXN2-3M0 squamous cell carcinoma of the penis.
Phase:
Phase 2
Details
Lead Sponsor:
M.D. Anderson Cancer Center
Treatments:
Albumin-Bound Paclitaxel
Cisplatin
Ifosfamide
Isophosphamide mustard
Paclitaxel